COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,234 Articles (22,733 medRxiv, 8,501 bioRxiv)

Most recent first Previous |  Page 1230: Articles 12291-12300  | Next

Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant Surge
Baden, L. R., ElSahly, H. M., Essink, B., Follman, D., Neuzil, K. M., August, A., Clouting, H., Fortier, G., Deng, W., Han, S., Zhao, X., Leav, B., Talarico, C., Girard, B., Paila, Y., Tomassini, J. E., Schodel, F., Pajon, R., Zhou, H., Das, R., Miller, J.
10.1101/2021.09.17.21263624 — Posted: 2021-09-22 Discussion: Onsite
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals
Lederer, K., Parvathaneni, K., Painter, M. M., Bettini, E., Agarwal, D., Lundgreen, K. A., Weirick, M., Goel, R. R., Xu, X., Drapeau, E. M., Gouma, S., Greenplate, A. R., Le Coz, C., Romberg, N., Jones, L., Rosen, M., Besharatian, B., Kaminiski, M., Weiskopf, D., Sette, A., Hensley, S. E., Bates, P., Wherry, E. J., Naji, A., Bhoj, V., Locci, M.
10.1101/2021.09.16.21263686 — Posted: 2021-09-21
Clinical Results with a B Cell Activating Anti-CD73 Antibody for the Immunotherapy of COVID-19
Miller, R. A., Guru, P., Bauer, P., Robles, J., Tomaszewski, C., Overcash, J. S., Waters, M., Cameron, M., Olalla Sierra, J., Janc, J., Rudnick, J. A., Hu, S., Jones, W. B., Kwei, L., Mahabhashyam, S., Willingham, S. B., Criner, G.
10.1101/2021.09.13.21263406 — Posted: 2021-09-21
Effectiveness of vaccination in preventing severe SARS CoV-2 infection in South India-a hospital based cross sectional study
ruban, A. c. p., Mohamed, A., Kalyanaraman, S.
10.1101/2021.09.17.21263670 — Posted: 2021-09-21
Prior Covid-19 and high RBD-IgG levels correlate with protection against VOC-delta SARS-CoV-2 infection in vaccinated Nursing Home Residents
Blain, H., TUAILLON, E., Pisoni, A., Soriteau, L., Million, E., Leglise, M.-S., Bussereau, I., Miot, S., Rolland, Y., Picot, M.-C., Bousquet, J. J.
10.1101/2021.09.21.21263880 — Posted: 2021-09-21
An epi-evolutionary model to predict spore-producing pathogens adaptation to quantitative resistance in heterogeneous environments
Fabre, F., Burie, J.-B., Ducrot, A., Lion, S., Richard, Q., Djidjou-Demasse, R.
10.1101/423467 — Posted: 2021-09-21
Real-world serologic responses to Extended-interval and Heterologous COVID-19 mRNA vaccination in Frail Elderly - Interim report from a prospective observational cohort study
Vinh, D. C., Gouin, J.-P., Cruz-Santiago, D., Canac-Marquis, M., Bernier, S., Bobeuf, F., Sengupta, A., Brassard, J.-P., Guerra, A., Dziarmaga, R., Perez, A., Sun, Y., Li, Y., Roussel, L., Langelier, M., Ke, D., Arnold, C., Pelchat, M., Langlois, M.-A., Evans, T. G., Zhang, X., Mazer, B. D.
10.1101/2021.09.16.21263704 — Posted: 2021-09-21
Computational systematics of nutritional support of vaccination against viral and bacterial pathogens as prolegomena to vaccinations against COVID-19
Torshin, I. Y., Gromova, O. A., Chuchalin, A. G.
10.1101/2021.09.10.21263398 — Posted: 2021-09-21
Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and severe COVID-19 in the UK
Andrews, N., Tessier, E., Stowe, J., Gower, C., Kirsebom, F., Simmons, R., Gallagher, E., Chand, M., Brown, K., Ladhani, S., Ramsay, M., Lopez Bernal, J.
10.1101/2021.09.15.21263583 — Posted: 2021-09-21
A method to reduce ELISA serial dilution assay workload applied to SARS-CoV-2 and seasonal HCoVs
Pattinson, D., Jester, P., Guan, L., Yamayoshi, S., Chiba, S., Presler, R., Rao, H., Iwatsuki-Horimoto, K., Hagihara, M., Ikeda, N., Uchida, T., Mitamura, K., Halfmann, P., Neumann, G., Kawaoka, Y.
10.1101/2021.09.13.21263523 — Posted: 2021-09-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).